Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v7-EN
Language English English
Date Updated 2018-02-03 2017-12-21
Drug Identification Number 02250276 02250276
Brand name CEFTRIAXONE SODIUM FOR INJECTION, BP CEFTRIAXONE SODIUM FOR INJECTION, BP
Common or Proper name Ceftriaxone sodium Ceftriaxone sodium
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10x250mg vial 10x250mg vial
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-11-13 2017-11-13
Estimated end date
Actual end date 2017-12-20 2017-12-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments